Regina Link

Title: Inventor Spotlight: Regina Link from Münchenstein, CH

Introduction

Regina Link is a notable inventor based in Münchenstein, Switzerland. With a keen focus on biopharmaceutical innovations, she has made significant contributions to the field through her research and inventions. Her work continues to enhance therapeutic options for various medical conditions.

Latest Patents

Regina has been awarded one patent for her invention titled "Solubilized Apyrases, Methods and Use." This patent encompasses solubilized apyrase polypeptides, as well as nucleotides that encode these unique polypeptides. Furthermore, it describes pharmaceutical compositions that include solubilized apyrase polypeptides and outlines their therapeutic applications. The methods provided in this patent are particularly useful in preventing or treating tissue damage by administering the solubilized apyrase polypeptides or their corresponding pharmaceutical compositions.

Career Highlights

Regina Link is an employee at Novartis AG, a leading global healthcare company known for its innovative research and development. Her role at Novartis has allowed her to explore and develop groundbreaking solutions in the biopharmaceutical sector. With her expertise, she has contributed to significant advancements in therapeutic treatments.

Collaborations

Regina collaborates with Agostino Cirillo, among other colleagues, to push the boundaries of their research. Their collective efforts focus on enhancing the efficacy of their pharmaceutical innovations, particularly in areas aimed at mitigating tissue damage and improving patient outcomes.

Conclusion

Regina Link stands out as an influential inventor in the biopharmaceutical industry. Her work on solubilized apyrases illustrates the profound impact of innovative research on healthcare solutions. As she continues her career at Novartis AG, her contributions are expected to lead to further advancements in therapeutic applications that benefit patients around the world.